MASSIVE INTERNATIONAL STUDY OF “H” FROM AROUND THE WORLD

Aug 17, 2020 by

“Early Treatment with “H” — a Country-Based Analysis”

8.5.20 – updated on 8.16.20

[COMMENTS FROM DONNA GARNER:  This is a gigantic study on “H” using scientific/medical data gathered from all over the world.]

Bottomline:  “The [HCQ] treatment group has a 78.2% lower death rate.” 

IMPORTANT LINKS TO THE STUDY:

https://hcqtrial.com/

https://c19study.com/

==============================

VARIOUS QUOTES FROM THIS STUDY:

A study [Mitchell] provides an extensive discussion of the differences between the death rates of New York City and Lagos, Nigeria, which both received [COVID] infected travelers around the same time.

NYC’s high rate has been linked to population density, poverty, overcrowding, and ethnicity.

Lagos is a crowded urban center of about 22 million people with 30 families often in a single building sharing the same bathroom, and none of the factors mentioned favor reduced death rates in Lagos. Lagos further has lower quality of medical care.

Yet NYC had a death rate 600 times higher. The younger population can only account for a small part of this difference. Mitchell concludes that there is a crossover prophylactic effect of antimalarial agents [e.g., hydroxychloroquine] against COVID-19.

=====================

Pre-Exposure Prophylaxis (PrEP) Studies:

“We found 8 PrEP studies [BhattacharyaChatterjeeFerreiraGendelmanKhuranaMaciasMitchellZhong][Khurana] presents a study of hospital health care workers showing HCQ prophylaxis reduces COVID-19 significantly.” 

========================

The deaths in Marseille, France, compared to the deaths in Paris, France.  Marseille used early treatment with HCQ; Paris did not.  

Paris: +35 %  — Marseille:  -14 %

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.